Impact of yoga and naturopathy intervention on sex hormone binding globulin in a patient with polycystic ovarian syndrome - A case study
Abstract
Polycystic ovarian syndrome (PCOS), is a prevalent endocrine disorder that is distinguished by hyperandrogenaemia, chronic anovulation, and polycystic ovary morphology, and metabolic abnormalities. Serum SHBG levels may also be helpful as a treatment target and diagnostic biomarker for treating PCOS in women, according to new research. Anovulation, the phenotypic features of PCOS, and the advancement of ovarian pathology are all caused by decreased SHBG levels, which also increase the bioavailability of androgens. Medications like metformin come with certain negative effects yet offer temporary and symptomatic relief. They don't provide a long-term remedy for the illness. Patients with PCOS can lead better lives by managing their weight, regaining their androgen status, and normalising their insulin resistance with practices of yoga and naturopathy. This aids in the prevention of other associated non-communicable diseases. A 19 years old female presented to OPD of our hospital with the chief complaint of irregular menstruation for the period of 5 years. She claims her progressive weight gain is making her feeling down. According to the USG investigation, both ovaries were found to be normal in size with several tiny follicles measuring 2-4 mm in the periphery. The patient underwent yoga and naturopathy intervention for the management of PCOS. After three months of intervention, significant improvements were observed, including a reduction in weight from 81 kg to 75 kg and an…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.